<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://www.diabesityrounds.com/a/anagliptin-with-metformin-and-empagliflozin-reduces-hba1c-in-phase-iii-korean-tr</loc><news:news><news:publication><news:name>Diabesity Rounds</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-16T22:32:57.316Z</news:publication_date><news:title>Anagliptin with metformin and empagliflozin reduces HbA1c in Phase III Korean trial</news:title></news:news></url><url><loc>https://www.diabesityrounds.com/a/phase-3-trial-reports-bmi-changes-with-liraglutide-3-0-mg-in-children-aged-6-to-</loc><news:news><news:publication><news:name>Diabesity Rounds</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-16T22:18:20.548Z</news:publication_date><news:title>Phase 3 trial reports BMI changes with liraglutide 3.0 mg in children aged 6 to 11</news:title></news:news></url><url><loc>https://www.diabesityrounds.com/a/weekly-semaglutide-lowered-bmi-in-children-aged-6-to-under-12-with-obesity-phase-687</loc><news:news><news:publication><news:name>Diabesity Rounds</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-16T21:36:50.348Z</news:publication_date><news:title>Weekly semaglutide lowered BMI in children aged 6 to under 12 with obesity: phase 3 trial</news:title></news:news></url><url><loc>https://www.diabesityrounds.com/a/weekly-ribupatide-lowers-body-weight-over-48-weeks-in-chinese-adults-without-dia-684</loc><news:news><news:publication><news:name>Diabesity Rounds</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-16T21:36:27.441Z</news:publication_date><news:title>Weekly ribupatide lowers body weight over 48 weeks in Chinese adults without diabetes</news:title></news:news></url><url><loc>https://www.diabesityrounds.com/a/surmount-adolescents-tirzepatide-lowered-bmi-by-18-5-in-adolescents-at-72-weeks-683</loc><news:news><news:publication><news:name>Diabesity Rounds</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-16T21:35:43.202Z</news:publication_date><news:title>SURMOUNT-ADOLESCENTS: tirzepatide lowered BMI by 18.5% in adolescents at 72 weeks</news:title></news:news></url><url><loc>https://www.diabesityrounds.com/a/cagrisema-1-7-mg-and-1-0-mg-each-cut-bodyweight-more-than-placebo-in-redefine-9</loc><news:news><news:publication><news:name>Diabesity Rounds</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-16T04:45:20.873Z</news:publication_date><news:title>CagriSema 1.7 mg and 1.0 mg each cut bodyweight more than placebo in REDEFINE 9</news:title></news:news></url><url><loc>https://www.diabesityrounds.com/a/smart-insulin-pens-with-bolus-calculator-lowered-hba1c-more-than-tracking-only-p</loc><news:news><news:publication><news:name>Diabesity Rounds</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-15T20:17:17.655Z</news:publication_date><news:title>Smart insulin pens with bolus calculator lowered HbA1c more than tracking-only pens</news:title></news:news></url></urlset>